NovoCure (NVCR) Current Deferred Revenue (2015 - 2019)
NovoCure (NVCR) posted Current Deferred Revenue of $19.6 million for Q4 2019, up 4.32% sequentially from $18.8 million in Q4 2018, and up 4.32% YoY from $18.8 million in Q4 2018.
NovoCure (NVCR) Current Deferred Revenue (2015 - 2019) Analysis & Trends
NovoCure has reported Current Deferred Revenue for 5 years, with the latest figure at $19.6 million in Q4 2019.
- Quarterly Current Deferred Revenue rose 4.32% year-over-year to $19.6 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $19.6 million (up 4.32% YoY) and the FY2019 annual result came in at $19.6 million, up 4.32% from the prior year.
- Current Deferred Revenue advanced to $19.6 million in Q4 2019 per NVCR's latest filing, from $18.8 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $19.6 million in Q4 2019 and troughed at $52000.0 in Q4 2015.
- A 5-year average of $9.1 million and a median of $5.0 million in 2017 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2016 and 2019: Current Deferred Revenue jumped 4259.62% in 2016, then increased 4.32% in 2019.
- Over 5 years, Current Deferred Revenue stood at $52000.0 in 2015, then surged by 4259.62% to $2.3 million in 2016, then jumped by 118.75% to $5.0 million in 2017, then surged by 278.48% to $18.8 million in 2018, then grew by 4.32% to $19.6 million in 2019.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $19.6 million, $18.8 million, and $5.0 million for Q4 2019, Q4 2018, and Q4 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | NovoCure | 2.06 Bn | 1.62 Bn | 142.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 19.58 Mn |
| Dec 31, 2018 | 18.77 Mn |
| Dec 31, 2017 | 4.96 Mn |
| Dec 31, 2016 | 2.27 Mn |
| Dec 31, 2015 | 52,000.00 |